Detection of hepatitis C virus core antigen for early diagnosis of hepatitis C virus infection in plasma donor in China

World Journal of Gastroenterology

Volumn 13, Issue 19, 2007, Pages 2738-2742

  Zhang, He Qiu ^a   Li, Shao Bo ^b   Wang, Guo Hua ^a   Chen, Kun ^a   Song, Xiao Guo ^a   Feng, Xiao Yan ^a  

^a INSTITUTE OF BASIC MEDICAL SCIENCES   (China)

^b Hunan Kingda Gene Ltd Co   (China)

Author keywords

Anti HCV; Core antigen; HCV RNA; Hepatitis C virus

Indexed keywords

HEPATITIS C ANTIBODY; HEPATITIS C ANTIGEN; VIRUS RNA;

ANTIGEN DETECTION; ARTICLE; BLOOD DONOR; CHINA; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; EARLY DIAGNOSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; IMMUNOASSAY; INTERMETHOD COMPARISON; NONHUMAN; POLYMERASE CHAIN REACTION; QUALITATIVE ANALYSIS; SENSITIVITY AND SPECIFICITY; VIRUS DETECTION;

EID: 34250777106     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v13.i19.2738     Document Type: Article

References (25)

1. Choo QL, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 1989; 244: 359-362
2. Courouce AM. Development of screening and confirmation tests for antibodies to hepatitis C virus. Curr Stud Hematol Blood Transfus 1998; 64-75
3. van der Poel CL. Hepatitis C virus and blood transfusion: past and present risks. J Hepatol 1999; 31 Suppl 1: 101-106
4. Donahue JG, Munoz A, Ness PM, Brown DE Jr, Yawn DH, McAllister HA Jr, Reitz BA, Nelson KE. The declining risk of post-transfusion hepatitis C virus infection. N Engl J Med 1992; 327: 369-373
5. Wang YJ, Lee SD, Hwang SJ, Chan CY, Chow MP, Lai ST, Lo KJ. Incidence of post-transfusion hepatitis before and after screening for hepatitis C virus antibody. Vox Sang 1994; 67: 187-190
6. van der Poel CL, Cuypers HT, Reesink HW. Hepatitis C virus six years on. Lancet 1994; 344: 1475-1479
7. Schreiber GB, Busch MP, Kleinman SH, Korelitz JJ. The risk of transfusion-transmitted viral infections. The Retrovirus Epidemiology Donor Study. N Engl J Med 1996; 334:1685-1690
8. Courouce AM, Le Marrec N, Bouchardeau F, Razer A, Maniez M, Laperche S, Simon N. Efficacy of HCV core antigen detection during the preseroconversion period. Transfusion 2000; 40: 1198-1202
9. Muller-Breitkreutz K, Baylis SA, Allain J. Nucleic acid amplification tests for the detection of blood-borne viruses. 5th EPFA/ NIBSC Workshop, Amsterdam 1998. Vox Sang 1999; 76: 194-200
10. Seme K, Poljak M. Evaluation of the Amplicor HCV test: experiences after 1 year of routine use in a diagnostic laboratory. Infection 1996; 24:140-143
11. Poljak M, Seme K, Koren S. Evaluation of the automated COBAS AMPLICOR hepatitis C virus PCR system. J Clin Microbiol 1997; 35: 2983-2984
12. Roth WK, Weber M, Seffried E. Feasibility and efficacy of routine PCR screening of blood donations for hepatitis C virus, hepatitis B virus, and HIV-1 in a blood-bank setting. Lancet 1999; 353: 359-363
13. Du SC, Sun NX, Fan XF, Qiu GH, You P, Zhang YX, Wei L. Hepatitis C virus (HCV) 5′ NCR genotype research and 3b sequencing analysis in China. Zhonghua Jianyan Yixue Zazhi 2004; 27: 683-686
14. Reed KE, Rice CM. Overview of hepatitis C virus genome structure, polyprotein processing, and protein properties. Curr Top Microbiol Immunol 2000; 242: 55-84
15. Lai MM, Ware CF. Hepatitis C virus core protein: possible roles in viral pathogenesis. Curr Top Microbiol Immunol 2000; 242:117-134
16. Nelson DR, Marousis CG, Davis GL, Rice CM, Wong J, Houghton M, Lau JY. The role of hepatitis C virus-specific cytotoxic T lymphocytes in chronic hepatitis C. J Immunol 1997; 158: 1473-1481
17. Aoyagi K, Ohue C, fida K, Kimura T, Tanaka E, Kiyosawa K, Yagi S. Development of a simple and highly sensitive enzyme immunoassay for hepatitis C virus core antigen. J Clin Microbiol 1999; 37:1802-1808
18. Orito E, Mizokami M, Tanaka T, Lau JY, Suzuki K, Yamauchi M, Ohta Y, Hasegawa A, Tanaka S, Kohara M. Quantification of serum hepatitis C virus core protein level in patients chronically infected with different hepatitis C virus genotypes. Gut 1996; 39: 876-880
19. Netski DM, Wang XH, Mehta SH, Nelson K, Celentano D, Thongsawat S, Maneekarn N, Suriyanon V, Jittiwutikorn J, Thomas DL, Ticehurst JR. Hepatitis C virus (HCV) core antigen assay to detect ongoing HCV infection in thai injection drug users. J Clin Microbiol 2004; 42: 1631-1636
20. Fabrizi F, Lunghi G, Aucella F, Mangano S, Barbisoni F, Bisegna S, Vigilante D, Limido A, Martin P. Novel assay using total hepatitis C virus (HCV) core antigen quantification for diagnosis of HCV infection in dialysis patients. J Clin Microbiol 2005; 43:414-420
21. Valcavi P, Medici MC, Casula F, Arcangeletti MC, De Conto F, Pinardi F, Calderaro A, Chezzi C, Dettori G. Evaluation of a total hepatitis C virus (HCV) core antigen assay for the detection of antigenaemia in anti-HCV positive individuals. J Med Virol 2004; 73:397-403
22. Agha S, Tanaka Y, Saudy N, Kurbanov F, Abo-Zeid M, El-Malky M, Khalaf M, Ohta N, Yoshizawa H, Mizokami M. Reliability of hepatitis C virus core antigen assay for detection of viremia in HCV genotypes 1, 2, 3, and 4 infected blood donors: a collaborative study between Japan, Egypt, and Uzbekistan. J Med Virol 2004; 73: 216-222
23. Icardi G, Bruzzone B, Gota F, Torre F, Giannini E, Massone L, Li Bassi A, Lai PL, Picciotto A, Ansaldi F. A new assay for hepatitis C virus (HCV) core antigen detection: an alternative to nucleic acid technologies in positive or indeterminate anti-HCV subjects? Ann Ig 2003; 15: 863-870
24. Lee SR, Peterson J, Niven P, Bahl C, Page E, DeLeys R, Giordano-Schmidt D, Baggett D, Green G. Efficacy of a hepatitis C virus core antigen enzyme-linked immunosorbent assay for the identification of 'window-phase'blood donations. Vox Sang 2001; 50: 19-23
25. Peterson J, Green G, Iida K, Caldwell B, Kerrison P, Bernich S, Aoyagi K, Lee SR. Detection of hepatitis C core antigen in the antibody negative 'window' phase of hepatitis C infection. Vox Sang 2000; 78: 80-85